Tired of battling stubborn belly fat? Gastroenterologist Dr. Pal Manickam shares straightforward, long-term strategies to help shed those extra inches. Aim for a manageable calorie deficit, ...

You can lose weight without exercise by changing eating, sleep and daily habits. Tips include drinking water before meals and ...

Share on Pinterest Mounjaro helps maintain weight loss at 3-year landmark, study confirms. Image credit: NurPhoto/Getty Images. According to a new study, a once-weekly dose of tirzepatide can lead to ...

Tirzepatide, a once-weekly GIP/GLP-1 receptor agonist, is a medicine used for weight reduction in adults with obesity. A new analysis of the SURMOUNT clinical trials reveals that the medicine, ...

In the context of the global obesity epidemic, the FDA approved several glucagon-like peptide-1 (GLP-1) receptor agonists (GPL-1RAs), such as liraglutide (Saxenda) and semaglutide (Ozempic, Wegovy) as ...

Obesity is a chronic, relapsing and treatable multifactorial disease 1. Although safe and effective therapies are now available, persistence with existing injectable obesity management medications ...

Retatrutide met primary and key secondary endpoints in a 2339-participant, randomized, double-blind, placebo-controlled phase 3 trial, demonstrating clinically meaningful weight reduction across 4, 9, ...

Intermittent fasting (IF) has gained attention for weight management and metabolic health, but detailed trials comparing its efficacy to calorie restriction (CR) in type 2 diabetes mellitus (T2D) are ...

Data presented simultaneously at the American Diabetes Association’s® 85th Scientific Sessions, showed mean weight reduction in the highest range of efficacy observed with existing weight loss ...

A new once-a-month injection helped people with obesity shed up to 16% of their body weight, offering fresh hope for effective, long-acting treatments. Can this breakthrough change the landscape for ...